These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 17988786
1. Liposome destabilization induced by synthetic lipopeptides corresponding to envelope and non-structural domains of GBV-C/HGV virus. Conformational requirements for leakage. Fernández-Vidal M, Rojo N, Herrera E, Gómara MJ, Haro I. Biophys Chem; 2008 Jan; 132(1):55-63. PubMed ID: 17988786 [Abstract] [Full Text] [Related]
2. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide. Herrera E, Gomara MJ, Mazzini S, Ragg E, Haro I. J Phys Chem B; 2009 May 21; 113(20):7383-91. PubMed ID: 19402654 [Abstract] [Full Text] [Related]
3. Characterization of a putative fusogenic sequence in the E2 hepatitis G virus protein. Larios C, Casas J, Alsina MA, Mestres C, Gómara MJ, Haro I. Arch Biochem Biophys; 2005 Oct 15; 442(2):149-59. PubMed ID: 16165082 [Abstract] [Full Text] [Related]
4. Effects of overlapping GB virus C/hepatitis G virus synthetic peptides on biomembrane models. Larios C, Busquets MA, Carilla J, Alsina MA, Haro I. Langmuir; 2004 Dec 07; 20(25):11149-60. PubMed ID: 15568870 [Abstract] [Full Text] [Related]
6. Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection. Herrera E, Tenckhoff S, Gómara MJ, Galatola R, Bleda MJ, Gil C, Ercilla G, Gatell JM, Tillmann HL, Haro I. J Med Chem; 2010 Aug 26; 53(16):6054-63. PubMed ID: 20718496 [Abstract] [Full Text] [Related]
11. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior. Pascual R, Contreras M, Fedorov A, Prieto M, Villalaín J. Biochemistry; 2005 Nov 01; 44(43):14275-88. PubMed ID: 16245944 [Abstract] [Full Text] [Related]
15. 3D-Structure of the interior fusion peptide of HGV/GBV-C by 1H NMR, CD and molecular dynamics studies. Mazzini S, Fernandez-Vidal M, Galbusera V, Castro-Roman F, Bellucci MC, Ragg E, Haro I. Arch Biochem Biophys; 2007 Sep 01; 465(1):187-96. PubMed ID: 17603997 [Abstract] [Full Text] [Related]
17. A cyclic GB virus C derived peptide with anti-HIV-1 activity targets the fusion peptide of HIV-1. Galatola R, Vasconcelos A, Pérez Y, Cruz A, Pujol M, Alsina MA, Gómara MJ, Haro I. Eur J Med Chem; 2014 Oct 30; 86():589-604. PubMed ID: 25218908 [Abstract] [Full Text] [Related]
18. Interaction of lipidated GBV-C/HGV NS3 (513-522) and (505-514) peptides with phospholipids monolayer. An AFM study. Weroński KJ, Diez-Pérez I, Busquets MA, López-Iglesias C, Girona V, Prat J. Colloids Surf B Biointerfaces; 2010 Jan 01; 75(1):25-33. PubMed ID: 19765957 [Abstract] [Full Text] [Related]